| CXM481 | Cancer of the cervix paired with metastatic tumors in lymph nodes, 12 cases (1.5mm) | 12 Cases (1.5 mm) | Sign In for Pricing | |
| BNC402226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC943750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3750-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC472225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC042225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNCB3750-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC882226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC683750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), CF568 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB2225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUM3750-50 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
| NBP2-30286 | Human Metastatic Cancer to Ovary Tissue MicroArray | 1 Slide | Sign In for Pricing | |
| BNCB2225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC043750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC942226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUM2226-50 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
| BNC472226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC742225-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), CF740 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| LC953 | Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue , including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952 | 1 Each | Sign In for Pricing | |
| KD808 | Different stages of kidney cancer tissue array, containing metastatic carcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 1 Each | Sign In for Pricing | |
| SM208 | Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases/208 core, with stage and grade data | 1 Each | Sign In for Pricing | |
| BR1005b | Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a-BR1005b | each | Sign In for Pricing | |
| MLV801 | Liver metastatic cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 1 Each | Sign In for Pricing | |
| ES806 | Metastatic esophageal cancer tissue array, 40 cases/80 cores | 1 Each | Sign In for Pricing | |
| LC814a | Lung cancer tissue array with matched metastatic lymph node | each | Sign In for Pricing | |
| BR1008b | Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result. 100 cases/100 cores, replacing BR1008a-BR1008b | each | Sign In for Pricing | |
| KD603 | Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores | 1 Each | Sign In for Pricing | |
| BRM961a | Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores-BRM961a | each | Sign In for Pricing | |
| ES208a | Esophagus cancer and esophagus tissue array, with metastatic cancer, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing ES208 | 1 Each | Sign In for Pricing | |
| LV8011b | Liver disease spectrum (hepatic cancer progression) and liver tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing LV8011a | 1 Each | Sign In for Pricing | |
| KD951a | Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma | each | Sign In for Pricing | |
| EXOP-105A-1 | MDA-MB-231 Human breast cancer, aggressive/invasive/metastatic cell line: >1x10^10 frozen exosomes | 50 µg | Sign In for Pricing | |
| MBS6467316-01 | CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (PE) | 0.2 mL | Sign In for Pricing | |
| MBS6467316-02 | CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (PE) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6467296-01 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (APC) | 0.2 mL | Sign In for Pricing | |
| MBS6467296-02 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (APC) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6467299-01 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Azide free) (HRP) | 0.2 mL | Sign In for Pricing | |
| MBS6467299-02 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Azide free) (HRP) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6467303-01 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 650) | 0.1 mL | Sign In for Pricing | |
| MBS6467303-02 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 650) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6467305-01 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (PE) | 0.2 mL | Sign In for Pricing | |
| MBS6467305-02 | CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (PE) | 5x 0.2 mL | Sign In for Pricing | |
| MBS6467307-01 | CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (APC) | 0.2 mL | Sign In for Pricing | |
| MBS6467307-02 | CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (APC) | 5x 0.2 mL | Sign In for Pricing | |
| MBS4380892-01 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 0.02 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4380892-02 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4380892-03 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| MBS4380892-04 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 5x 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4380892-05 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 5x 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |